Avandia (rosiglitazone) is now approved to be used with insulin in patients with type 2 diabetes

April 2003

Avandia (rosiglitazone) is now approved to be used with insulin in patients with type 2 diabetes.

Until now, Actos (pioglitazone) was the only glitazone approved for use with insulin.

Adding a glitazone to insulin lowers blood glucose...allowing many patients to reduce their insulin dose.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote